A Study to Investigate the Effect of Baxdrostat on Ambulatory Blood Pressure in Participants With Resistant Hypertension
Conditions: Resistant Hypertension Interventions: Drug: Baxdrostat; Drug: Placebo Sponsors: AstraZeneca Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 13, 2023 Category: Research Source Type: clinical trials
Effect of Nitrate Supplementation on Blood Pressure and Microvascular Function of Resistant Hypertensive Patients
Conditions: Arterial Hypertension; Resistant Hypertension; Microvascular Function; Nitrate Supplementation Interventions: Dietary Supplement: Beetroot extract Sponsors: National Institute of Cardiology, Laranjeiras, Brazil Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 13, 2023 Category: Research Source Type: clinical trials
Female Community Health Volunteers Led Hypertension Prevention and Control in Nepal
Conditions: Hypertension Interventions: Behavioral: Intervention Group Sponsors: Kathmandu University School of Medical Sciences; World Health Organization; Institute for Implementation Science and Health Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 11, 2023 Category: Research Source Type: clinical trials
A Study to Evaluate the Efficacy and Safety of Co-administrated BR1018B and BR1018C
Conditions: Essential Hypertension; Primary Hypercholesterolemia Interventions: Drug: BR1018A; Drug: BR1018A-1; Drug: BR1018B; Drug: BR1018B-1; Drug: BR1018C; Drug: BR1018C-1 Sponsors: Boryung Pharmaceutical Co., Ltd Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 11, 2023 Category: Research Source Type: clinical trials
Consumer Responses to Alcohol Warnings
Conditions: Alcohol Drinking Interventions: Behavioral: Mouth cancer warning; Behavioral: Throat cancer warning; Behavioral: Voice box (larynx) warning; Behavioral: Esophagus cancer warning; Behavioral: Liver cancer warning; Behavioral: Colon and rectum cancer warning; Behavioral: Breast cancer; Behavioral: Cancer (generic, not site-specific); Behavioral: Addiction and neurological changes; Behavioral: Hypertension; Behavioral: Liver damage; Behavioral: Harm to fetus; Behavioral: Dementia; Behavioral: Impaired sleep; Behavioral: Drinking guidelines; Behavioral: Control; Behavioral: Road injuries Sponsors: Stanford Universi...
Source: ClinicalTrials.gov - December 7, 2023 Category: Research Source Type: clinical trials
Correlation of Ultrasonography Indices of Venous Congestion With Intra-abdominal Pressure in ICU Patients.
Conditions: Intra-Abdominal Hypertension; Venous Congestion Interventions: Diagnostic Test: Abdominal ultrasound Sponsors: National and Kapodistrian University of Athens Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 7, 2023 Category: Research Source Type: clinical trials
Prognostic Model of Hypertension
Conditions: Hypertension Interventions: Other: Standard therapy Sponsors: Xinjiang Medical University Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 7, 2023 Category: Research Source Type: clinical trials
Uncontrolled Hypertension Management Among Jordanian Adults
Conditions: Hypertension; Physical Activity; Dietary Habits; Medication Adherence; Motivational Interviewing Interventions: Behavioral: DASH-ExMAMI Sponsors: Universiti Sains Malaysia Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 5, 2023 Category: Research Source Type: clinical trials
Yoga for a Healthy Heart
Conditions: Hypertension Interventions: Behavioral: Therapeutic yoga Sponsors: The Cleveland Clinic Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 4, 2023 Category: Research Source Type: clinical trials
Phase 2 Trial Evaluating Travoprost Ophthalmic Topical Cream in Subjects With Open-angle Glaucoma or Ocular Hypertension
Conditions: Open Angle Glaucoma; Ocular Hypertension Interventions: Drug: Travoprost Ophthalmic Topical Cream low-dose; Drug: Travoprost Ophthalmic Topical Cream mid-dose; Drug: Travoprost Ophthalmic Topical Cream high-dose; Drug: Timolol maleate ophthalmic solution, 0.5%; Drug: Travoprost Ophthalmic Solution, 0.004% Sponsors: Glaukos Corporation Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 1, 2023 Category: Research Source Type: clinical trials
KIdney aNd blooD prESsure ouTcomes in Childhood Cancer Survivors (CCS)
Conditions: Childhood Cancer; Chronic Kidney Diseases; Hypertension; Acute Kidney Injury; Nephrotoxicity Sponsors: The Hospital for Sick Children Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 1, 2023 Category: Research Source Type: clinical trials
Efficacy and Safety of Lorundrostat in Subjects With Uncontrolled and Resistant Hypertension
Conditions: Hypertension Interventions: Drug: Placebo; Drug: lorundrostat Dose 1; Drug: lorundrostat Dose 2 Sponsors: Mineralys Therapeutics Inc. Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 1, 2023 Category: Research Source Type: clinical trials
Travoprost Ophthalmic Topical Cream for Open-angle Glaucoma or Ocular Hypertension
Conditions: Open Angle Glaucoma; Ocular Hypertension Interventions: Drug: Travoprost Ophthalmic Topical Cream low-dose; Drug: Travoprost Ophthalmic Topical Cream mid-dose; Drug: Travoprost Ophthalmic Topical Cream high-dose; Drug: Timolol maleate ophthalmic solution, 0.5%; Drug: Travoprost Ophthalmic Solution, 0.004% Sponsors: Glaukos Corporation Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 1, 2023 Category: Research Source Type: clinical trials
UCSF BP Activate Letter Randomized Clinical Trial
Conditions: Hypertension Interventions: Other: BP Activate Letter; Other: Control Letter Sponsors: University of California, San Francisco Active, not recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 30, 2023 Category: Research Source Type: clinical trials
Evaluation of Hypertension Management and Cardiovascular Adverse Event Prevention in Patients With B-cell Malignancies Undergoing Treatment With Bruton Tyrosine Kinase Inhibitors, the HALT Study
Conditions: Chronic Lymphocytic Leukemia; Hematopoietic and Lymphoid System Neoplasm; Mantle Cell Lymphoma; Marginal Zone Lymphoma; Waldenstrom Macroglobulinemia Interventions: Other: Non-Interventional Study Sponsors: Mayo Clinic Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 30, 2023 Category: Research Source Type: clinical trials
